Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for stages III–IV, unresectable ovarian cancer: a single-arm, open-label, phase Ib/II study

Abstract Background Neoadjuvant chemotherapy may be considered for patients with ovarian cancer (OC) whose tumors are deemed unlikely to be completely cytoreduced to no gross residual disease (R0) or who are poor surgical candidates. This Ib/II study was designed to assess the efficacy and safety of...

Description complète

Détails bibliographiques

Auteurs principaux:	Lina Yin, Wei Jiang, Shuai Liu, Yi Fu, Lin Zhou, Xuan Pei, Shuang Ye, Wenbin Shen, Huijuan Yang, Boer Shan
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2024-10-01
Collection:	BMC Medicine
Sujets:	Nanoparticle albumin-bound paclitaxel Carboplatin Stages III–IV Unresectable ovarian cancer Phase Ib/II study Neoadjuvant treatment
Accès en ligne:	https://doi.org/10.1186/s12916-024-03697-1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!